Literature DB >> 30014358

From autoinflammation to autoimmunity: old and recent findings.

Francesco Caso1, Luisa Costa1, Valeria Nucera2, Giuseppe Barilaro3, Ignazio Francesco Masala4, Rossella Talotta5, Paolo Caso6, Raffaele Scarpa7, Piercarlo Sarzi-Puttini5, Fabiola Atzeni2.   

Abstract

Autoimmune diseases and autoinflammatory diseases have a number of similar etiopathogenetic and clinical characteristics, including genetic predisposition and recurrent systemic inflammatory flares. The first phase of ADs involves innate immunity: by means of TLRs, autoantigen presentation, B and T cell recruitment and autoantibody synthesis. The second phase involves adaptive immunity, a self-sustaining process in which immune complexes containing nucleic acids and autoantibodies activate self-directed inflammation. The link between autoimmunity and autoinflammation is IL-1ß, which is crucial in connecting the innate immune response due to NLR activation and the adaptive immune responses of T and B cells. In conclusion, although ADs are still considered adaptive immunity-mediated disorders, there is increasing evidence that innate immunity and inflammasomes are also involved. The aim of this review is to highlight the link between the innate and adaptive immune mechanisms involved in autoimmune diseases.

Entities:  

Keywords:  Adaptive and innate immunity; Autoimmune diseases; Autoinflammatory diseases; T and B cells

Mesh:

Substances:

Year:  2018        PMID: 30014358     DOI: 10.1007/s10067-018-4209-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  215 in total

1.  Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).

Authors:  Andrew P Demidowich; Alexandra F Freeman; Douglas B Kuhns; Ivona Aksentijevich; John I Gallin; Maria L Turner; Daniel L Kastner; Steven M Holland
Journal:  Arthritis Rheum       Date:  2011-12-12

2.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

3.  PSMB8 encoding the β5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome.

Authors:  Anil K Agarwal; Chao Xing; George N DeMartino; Dario Mizrachi; Maria Dolores Hernandez; Ana Berta Sousa; Laura Martínez de Villarreal; Heloísa G dos Santos; Abhimanyu Garg
Journal:  Am J Hum Genet       Date:  2010-12-10       Impact factor: 11.025

4.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

Review 5.  Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype.

Authors:  Austen Worth; Adrian J Thrasher; H Bobby Gaspar
Journal:  Br J Haematol       Date:  2006-04       Impact factor: 6.998

6.  Is Still's Disease an Autoinflammatory Syndrome?

Authors:  Linda Rossi-Semerano; Isabelle Koné-Paut
Journal:  Int J Inflam       Date:  2012-04-26

7.  Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials.

Authors:  Susan Manzi; Jorge Sánchez-Guerrero; Joan T Merrill; Richard Furie; Dafna Gladman; Sandra V Navarra; Ellen M Ginzler; David P D'Cruz; Andrea Doria; Simon Cooper; Z John Zhong; Douglas Hough; William Freimuth; Michelle A Petri
Journal:  Ann Rheum Dis       Date:  2012-05-01       Impact factor: 19.103

8.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

Review 9.  αβ T cell receptors as predictors of health and disease.

Authors:  Meriem Attaf; Eric Huseby; Andrew K Sewell
Journal:  Cell Mol Immunol       Date:  2015-01-26       Impact factor: 11.530

10.  An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome.

Authors:  Scott W Canna; Adriana A de Jesus; Sushanth Gouni; Stephen R Brooks; Bernadette Marrero; Yin Liu; Michael A DiMattia; Kristien J M Zaal; Gina A Montealegre Sanchez; Hanna Kim; Dawn Chapelle; Nicole Plass; Yan Huang; Alejandro V Villarino; Angelique Biancotto; Thomas A Fleisher; Joseph A Duncan; John J O'Shea; Susanne Benseler; Alexei Grom; Zuoming Deng; Ronald M Laxer; Raphaela Goldbach-Mansky
Journal:  Nat Genet       Date:  2014-09-14       Impact factor: 38.330

View more
  6 in total

1.  "Listen to Your Immune System When It's Calling for You": Monitoring Autoimmune Diseases Using the iShU App.

Authors:  Cláudia Ortet; Liliana Vale Costa
Journal:  Sensors (Basel)       Date:  2022-05-18       Impact factor: 3.847

Review 2.  Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.

Authors:  Yhojan Rodríguez; Lucia Novelli; Manuel Rojas; Maria De Santis; Yeny Acosta-Ampudia; Diana M Monsalve; Carolina Ramírez-Santana; Antonio Costanzo; William M Ridgway; Aftab A Ansari; M Eric Gershwin; Carlo Selmi; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2020-06-16       Impact factor: 7.094

Review 3.  Centrality of Myeloid-Lineage Phagocytes in Particle-Triggered Inflammation and Autoimmunity.

Authors:  Olivia K Favor; James J Pestka; Melissa A Bates; Kin Sing Stephen Lee
Journal:  Front Toxicol       Date:  2021-11-04

Review 4.  Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders.

Authors:  Piero Ruscitti; Alessandro Conforti; Marco Tasso; Luisa Costa; Francesco Caso; Paola Cipriani; Roberto Giacomelli
Journal:  Adv Rheumatol       Date:  2021-07-08

Review 5.  Targeting co-stimulatory molecules in autoimmune disease.

Authors:  Natalie M Edner; Gianluca Carlesso; James S Rush; Lucy S K Walker
Journal:  Nat Rev Drug Discov       Date:  2020-09-16       Impact factor: 112.288

Review 6.  Autoimmunity as the comet tail of COVID-19 pandemic.

Authors:  Rossella Talotta; Erle Robertson
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.